Clinical Trial Update: Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of vitamin D3 supplementation on inflammation markers in high-risk cardiovascular patients with chronic kidney disease was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Coronary Artery Disease
• Hyperparathyroidism
• Hypovitaminosis

Drugs mentioned

• Vitamin D3 supplement (Cholecalciferol)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Coronary Artery Disease, Chronic Kidney Disease | Phase 3 | Status: TERMINATED | Results posted: 2013-11-11